Idenix challenges Gilead's patent rights to methods of treating HCV with Sovaldi® (sofosbuvir)
Clients Idenix Pharmaceuticals LLC
Jones Day represents Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in a patent interference against Gilead. Subject matter is methods for treating a host infected with hepatitis C virus by administering a nucleoside analog or prodrug.
Storer v. Clark, Interference 105,981 (USPTO Patent Trial and Appeal Board)